Instructions for
Authors
ONLINE MANUSCRIPT SUBMISSION: An online
submission and tracking service via Internet facilitates
a speedy and cost-effective submission of manuscripts. The
full manuscript has to be submitted online via Bentham's
Content Management System (CMS) at http://bsp-cms.eurekaselect.com/
View
Submission Instructions
Manuscripts must be submitted by one of the authors of the
manuscript, and should not be submitted by anyone on their
behalf. The principal/corresponding author will be required
to submit a Covering Letter along with the manuscript, on
behalf of all the co-authors (if any). The author(s) will
confirm that the manuscript (or any part of it) has not been
published previously or is not under consideration for publication
elsewhere. Furthermore, any illustration, structure or table
that has been published elsewhere must be reported, and copyright
permission for reproduction must be obtained.
For all online submissions, please provide soft copies of
all the materials (main text in MS Word or Tex/LaTeX), figures
/ illustrations in TIFF, PDF or JPEG, and chemical structures
drawn in ChemDraw (CDX) / ISISDraw (TGF) as separate files,
while a PDF version of the entire manuscript must also be
included, embedded with all the figures / illustrations /
tables / chemical structures etc. It is advisable that the
document files related to a manuscript submission should always
have the name of the corresponding author as part of the file
name, i.e., “Cilli MS text.doc” , “Cilli
MS Figure 1”, etc.
It is imperative that before submission, authors should carefully
proofread the files for special characters, mathematical symbols,
Greek letters, equations, tables, references and images, to
ensure that they appear in proper format.
References, figures, tables, chemical structures etc.
should be referred to in the text at the appropriate place
where they are first discussed. Figure legends/captions should
also be provided.
A successful electronic submission of a manuscript will be
followed by a system-generated acknowledgement to the principal/corresponding
author. Any queries therein should be addressed to ccp@benthamscience.org
or samina@benthamscience.org
MANUSCRIPTS PUBLISHED: The Journal accepts peer-reviewed
mini- and full-length review articles and drug clinical trial
studies written in English. Single topic/thematic issues may
also be considered for publication.
Single Topic Issues: These peer-reviewed issues will
be restricted to invited or uninvited review/mini-review articles
and drug clinical trial studies. A Single Topic Issue Editor
will offer a short perspective and co-ordinate the solicitation
of manuscripts between 3-5 (for a mini-hot topic) to 6-10
(for full-length hot topic) from leading scientists. Authors
interested in editing a single topic issue in an emerging
topic of pharmacology may submit their proposal to the Editor-in-Chief
at ccp@benthamscience.org
for consideration.
MANUSCRIPT LENGTH:
Review Articles: The total number of words for a
published comprehensive review article article is from 8000
to 40000 words, and for mini-review articles from 3000 to
6000 words.
There is no restriction on the number of figures,
tables or additional files e.g. video clips, animation and
datasets, that can be included with each article online. Authors
should include all relevant supporting data with each article
(Refer to Supplementary Material section).
Drug Clinical Trial Studies: Drug clinical
trial studies are biomedical or health-related interventional
and/or observational research studies conducted in phases
in human beings that follow a pre-defined protocol.The study
is intended to find out whether promising approaches to the
disease prevention, diagnosis, and treatment are safe and
effective. The maximum total page length for a drug clinical
trial study published in the journal is four journal pages.
Each journal page is on average 900 words.
MANUSCRIPT PREPARATION: The manuscript should be
written in English in a clear, direct and active style. All
pages must be numbered sequentially, facilitating in the reviewing
and editing of the manuscript.
For further convenience, the customer support team
available at Bentham Publishing Services (www.benthampublishingservices.com)
can provide assistance to authors for the preparation of manuscripts.
MANUSCRIPT SECTIONS FOR PAPERS: Manuscripts may be
divided into the following sections:
Covering letter
Title
Title page
Abstract
Keywords
Text organization
List of abbreviations (if any)
Conflict of interest (if any)
Acknowledgements (if any)
References
Appendices
Figures/illustrations (if any)
Chemical structures (if any)
Tables (if any)
Supportive/supplementary material (if any)
Covering Letter: It is mandatory that a signed covering
letter also be submitted along with the manuscript by the
author to whom correspondence is to be addressed, delineating
the scope of the submitted article declaring the potential
competing interests, acknowledging contributions from authors
and funding agencies, and certifying that the paper is prepared
according to the 'Instructions for Authors'.
All inconsistencies in the text and in the reference section,
and any typographical errors must be carefully checked and
corrected before the submission of the manuscript. The article
contains no such material or information that may be unlawful,
defamatory, fabricated, plagiarized, or which would, if published,
in any way whatsoever, violate the terms and conditions as
laid down in the copyright agreement. The authors acknowledge
that the publishers have the legal right to take appropriate
action against the authors for any such violation of the terms
and conditions as laid down in the copy right agreement. DOWNLOAD
COVERING LETTER
Title: The title of the article should be precise
and brief and must not be more than 120 characters. Authors
should avoid the use of non-standard abbreviations. The title
must be written in title case except for articles, conjunctions
and prepositions.
Authors should also provide a short ‘running
title’. Title, running title, byline, correspondent
footnote and keywords should be written as presented in original
manuscripts.
Title Page: Title page should include paper title,
author(s) full name and affiliation, corresponding author(s)
names complete affiliation/address, along with phone, fax
and email.
Abstract: The abstract should not exceed 250 words
for review papers and 150 words for drug clinical trial studies
summarizing the essential features of the article.
Keywords: Provide 6 to 8 keywords in alphabetical
order.
Text Organization: The main text should begin
on a separate page and should be divided into title page,
abstract and the main text. The text may be subdivided further
according to the areas to be discussed, which should be followed
by the Acknowledgement, List of Abbreviations, Conflict of
Interest (if any) and Reference sections. For Research Articles/Letters
the manuscript should begin with the title page and abstract
followed by the main text, which must be structured into separate
sections as Introduction, Materials and Methods, Results,
Discussion, and Conclusion, Acknowledgements, List of Abbreviations,
Conflict of Interest (if any) and References. If your research
article reports the results of a controlled health care intervention
such as a Drug Clinical Trial Studies/Case Report, list your
trial registry, along with the unique identifying number.
For Review, the manuscript should mention any previous important
recent and old reviews in the field and contain a comprehensive
discussion starting with the general background of the field.
It should then go on to discuss the salient features of recent
developments. The authors should avoid presenting material
which has already been published in a previous review. The
authors are advised to present and discuss their observations
in brief. The manuscript style must be uniform throughout
the text and 10 pt Times New Roman fonts should be used. The
full term for an abbreviation should precede its first appearance
in the text unless it is a standard unit of measurement. The
reference numbers should be given in square brackets in the
text. Italics should be used for Binomial names of organisms
(Genus and Species), for emphasis and for unfamiliar words
or phrases. Non-assimilated words from Latin or other languages
should also be italicized e.g. per se, et al. etc.
Trial registration: There should
be no space between the letters and numbers of your trial
registration number. All drug clinical trial studies, regardless
of when they were completed, and secondary analyses of original
drug clinical trial studies must be registered before submission
of a manuscript based on the trial. Studies designed for other
purposes, such as to study pharmacokinetics or major toxicity
(e.g., phase 1 trials), are exempt. Trial registry name, registration
identification number, and the URL for the registry should
be included at the end of abstract and also in the space provided
on the online manuscript submission form.
Authors will submit the Trial Protocols along with their manuscript.
The CONSORT (Consolidated Standards of Reporting Trials)
Checklist
and Flowchart is also required when submitting
the results of randomized control trials (RCTs).
Ethical Approval of Studies and Informed Consent:
For human or animal experimental investigations, it is a prerequisite
to provide a formal review and approval, or review and waiver,
by an appropriate institutional review board or ethics committee
and should be documented in your paper. For investigations
undertaken on human subjects, state in the Methods section
the manner in which the informed consent was obtained from
the study participants (i.e., oral or written), where there
is an unavoidable risk of breach of privacy e.g., in a clinical
photograph or in case details- the patient's written consent
or that of the next of kin, to publication must be obtained.
We will ask you to send a signed consent form before publication.
Consent must be obtained for all Case Reports and Drug Clinical
Trial Studies.
Greek Symbols and Special Characters: Greek
symbols and special characters often undergo formatting changes
and get corrupted or lost during preparation of manuscript
for publication. To ensure that all special characters used
are embedded in the text, these special characters should
be inserted as a symbol but should not be a result of any
format styling (Symbol font face) otherwise they
will be lost during conversion to PDF/XML.
Authors are encouraged to consult reporting guidelines. These
guidelines provide a set of recommendations comprising a list
of items relevant to their specific research design. Chemical
equations, chemical names, mathematical usage, unit of measurements,
chemical and physical quantity & units must conform to
SI and Chemical Abstracts or IUPAC.
All kinds of measurements should be reported only in International
System of Units (SI).
List of Abbreviations: If abbreviations are
used in the text either they should be defined in the text
where first used, or a list of abbreviations can be provided.
Conflict of Interest: Financial contributions
to the work being reported should be clearly acknowledged,
as should any potential conflict of interest.
Acknowledgements: Please acknowledge anyone
(individual/company/institution) who has contributed to the
study by making substantial contributions to conception, design,
acquisition of data, or analysis and interpretation of data,
or who was involved in drafting the manuscript or revising
it critically for important intellectual content. Please list
the source(s) of funding for the study, for each author, and
for the manuscript preparation in the acknowledgements section.
This journal complies with the International Committee of
Medical Journal Editors' Uniform Requirements for Manuscripts
Submitted to Biomedical Journals http://www.icmje.org
and the FDA's Good Reprint Practices for the Distribution
of Medical Journal Articles and Medical or Scientific Reference
Publications on Unapproved New Uses of Approved Drugs and
Approved or Cleared Medical Devices http://www.fda.gov/oc/op/goodreprint.html
Protection of Human Subjects and Animals in Research:
When reporting experiments involving human subjects, authors
should indicate whether the procedures followed were in accordance
with the ethical standards of the responsible committee on
human experimentation (institutional and national) and with
the Helsinki Declaration of 1975, as revised in 2000.
For research involving animals, authors should indicate whether
the procedures followed were in accordance with the standards
set forth in the Guide for the Care and Use of Laboratory
Animals (published by the National Academy of Science, National
Academy Press, Washington, D.C.).
References: References must be listed in
the Vancouver Style only. All references should be numbered
sequentially [in square brackets] in the text and listed in
the same numerical order in the reference section. The reference
numbers must be finalized and the bibliography must be fully
formatted before submission.
See below few examples of references listed in the correct
Vancouver Style:
Typical Paper Reference:
[1] Skelton JA, Cook SR, Auinger P, Klein JD, Barlow SE. Prevalence
and trends of severe obesity among US children and adolescents.
Acad Pediatr 2009; 9: 322-9.
[2] Kirkham TC. Cannabinoids and appetite: food craving and
food pleasure. Int Rev Psychiatry 2009; 21: 163-71.
Typical Chapter Reference:
[3] Serpe L. Conventional chemotherapeutic drug nanoparticles
for cancer treatment. In: Challa SSR Kumar Ed. Nanomaterials
for cancer therapy. Wiley-VCH Verlag GmbH &Co., Weinheim,
2006; Chap. 1: pp. 1-39.
Book Reference:
[4] Crabtree RH. The Organometallic Chemistry of the Transition
Metals. 3rd ed. Wiley &
Sons: New York 2001.
Book Chapter Reference:
[5] Wheeler DMS, Wheeler MM. In: Studies in Natural Products
Chemistry; Atta-ur-Rahman, Ed. Elsevier Science B. V: Amsterdam
1994; 14: pp. 3-46.
Conference Proceedings:
[6] Bengtsson S, Solheim BG. Enforcement of data protection,
privacy and security in medical informatics. In: Lun KC, Degoulet
P, Piemme TE, Rienhoff O, Eds. MEDINFO 92. Proceedings of
the 7th World Congress on Medical Informatics; 1992 Sep 6-10;
Geneva, Switzerland. Amsterdam: North-Holland 1992; pp. 1561-5.
[7] Kimura J, Shibasaki H, Eds. Recent advances in clinical
neurophysiology. Proceedings of the 10th International Congress
of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto,
Japan. Amsterdam: Elsevier 1996.
URL(WebPage):
[8] National Library of Medicine. Specialized Information
Services: Toxicology and Environmental Health. http://sis.nlm.nih.gov/Tox/ToxMain.html
(Accessed May 23, 2004).
Patent:
[9] Hoch JA, Huang S. Screening methods for the identification
of novel antibiotics. US Patent 6,043,045, March 28, 2000.
Thesis:
[10] Mackel H. Capturing the Spectra of Silicon
Solar Cells. PhD Thesis, The Australian National University:
Canberra, December 2004.
E-citations:
[11] Citations for articles/material published exclusively
online or in open access (free-to-view) , must contain the
exact Web addresses (URLs) at the end of the reference(s),
except those posted on an author’s Web site unless editorially
essential, e.g. ‘Reference: Available from: URL’.
Some important points to remember:
• All references must be complete and accurate.
• If the number of authors exceeds six then et al
will be used after three names (the term “et al.”
should be in italics).
• Online citations should include the date of access.
• Journal abbreviations should follow the Index
Medicus/MEDLINE.
• Take special care of the punctuation convention as
described in the above-mentioned examples.
• Superscript in the in-text citations and reference
section should be avoided.
• Abstracts, unpublished data and personal communications
(which can only be included if prior permission has been obtained)
should not be given in the reference section but they may
be mentioned in the text and details provided as footnotes.
• The authors are encouraged to use a recent version
of EndNote (version 5 and above) or Reference Manager (version
10) when formatting their reference list, as this allows references
to be automatically extracted.
Appendices: In case there is a need to present
lengthy, but essential methodological details, use appendices,
which can be a part of the article. An appendix must not exceed
three pages (Times New Roman, 12 point fonts, 900 max. words
per page). The information should be provided in a condensed
form, ruling out the need of full sentences. A single appendix
should be titled APPENDIX, while more than one can be titled
APPENDIX A, APPENDIX B, and so on.
Figures/Illustrations:
All authors must strictly follow the guidelines below
for preparing illustrations for publication in Current
Clinical Pharmacology. If the figures are found
to be sub-standard, then the manuscripts will be rejected/
and the authors offered the option of figure improvement professionally
by Bentham Publishing Services.
The costs for such improvement will be charged to the authors.
The authors should provide the illustrations as separate files,
as well as embedded in the text file, numbered consecutively
in the order of their appearance. Each figure should include
a single illustration. Each figure should be closely cropped
to minimize the amount of white space surrounding the illustration.
If a figure consists of separate parts, it is important that
a single composite illustration file be submitted, containing
all parts of the figure.
Photographs should be provided with a scale bar if appropriate,
as well as high-resolution component files.
Scaling/Resolution
For Line Art image type, which is generally an image
based on lines and text and does not contain tonal or shaded
areas, the preferred file format is TIFF or EPS, with colour
mode being Monochrome 1-bit or RGB, in a resolution of 900-1200
dpi. For Halftone image type, which is generally a continuous
tone photograph and contains no text, the preferred file format
is TIFF, with colour mode being or RGB or Grayscale, in a
resolution of 300 dpi.
For Combination image type, which is generally an image containing
halftone in addition to text or line art elements, the preferred
file format is TIFF, with colour mode being or RGB or Grayscale,
in a resolution of 500-900 dpi.
Formats
For illustrations, the following file formats are acceptable:
• Illustrator
• EPS (preferred format for diagrams)
• PDF (also especially suitable for
diagrams)
• PNG (preferred format for photos
or images)
• Microsoft Word (version 5 and above;
figures must be a single page)
• PowerPoint (figures must be a single
page)
• TIFF
• JPEG (conversion should be done using
the original file)
• BMP
• CDX (ChemDraw)
• TGF (ISISDraw)
Bentham Science does not process figures submitted in GIF
format.
If the large size of TIFF or EPS figures acts as an obstacle
to online submission, authors may find that conversion to
JPEG format before submission results in significantly reduced
file size and upload time, while retaining acceptable quality.
JPEG is a 'lossy' format. However, in order to maintain acceptable
image quality, it is recommended that JPEG files are saved
at High or Maximum quality.
Files should not be compressed with tools such as Zipit or
Stuffit prior to submission as these tools will in any case
produce negligible file-size savings for JPEGs and TIFFs,
which are already compressed.
Please do not:
1. Supply embedded graphics in your word processor (spreadsheet,
presentation) document;
2. Supply files that are optimized for screen use (like GIF,
BMP, PICT, WPG); the resolution is too low;
3. Supply files that are too low in resolution;
4. Submit graphics that are disproportionately large for the
content.
Image Conversion Tools:
There are many software packages, many of them freeware or
shareware, capable of converting to and from different graphics
formats, including PNG.
Good general tools for image conversion include GraphicConverter
on the Macintosh, PaintShop Pro, for Windows, and ImageMagick,
which is available on Macintosh, Windows and UNIX platforms.
Note that bitmap images (e.g. screenshots) should not be converted
to EPS, since this will result in a much larger file size
than the equivalent JPEG, TIFF, PNG or BMP, with no increase
in quality. EPS should only be used for images produced by
vector-drawing applications such as Adobe Illustrator or CorelDraw.
Most vector-drawing applications can be saved in, or exported
as, EPS format. In case the images have been originally prepared
in an Office application, such as Word or PowerPoint, then
the original Office files should be directly uploaded to the
site, instead of being converted to JPEG or another format
that may be of low quality.
Color Figures/Illustrations:
• The cost for the first
published page of color figures is US$ 965;
the second additional page will be for US$ 705
and each subsequent page for US$ 480.
• Color figures should be supplied in CMYK not
RGB colors.
Chemical Structures:
Chemical structures must be prepared in ChemDraw/CDX and provided
as separate file.
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120°
Bond spacing 18% of width
Fixed length 14.4
pt (0.500cm, 0.2in)
Bold width
2.0 pt (0.071cm, 0.0278in)
Line width 0.6
pt (0.021cm, 0.0084in)
Margin width 1.6 pt
(0.096cm)
Hash spacing 2.5 pt (0.088cm, 0.0347in)
Text settings:
Font
Times New Roman
Size
8 pt
Under the Preference Choose:
Units
points
Tolerances 3
pixels
Under Page Setup Use:
Paper
US letter
Scale
100%
Tables:
• Data Tables should be submitted in Microsoft Word
table format.
• Each table should include a title/caption being explanatory
in itself with respect to the details discussed in the table.
Detailed legends may then follow.
• Table number in bold font i.e. Table 1,
should follow a title. The title should be in small case with
the first letter in caps. A full stop should be placed at
the end of the title.
• Tables should be embedded in the text exactly according
to their appropriate placement in the submitted manuscript.
• Columns and rows of data should be made visibly distinct
by ensuring that the borders of each cell are displayed as
black lines.
• Tables should be numbered in Arabic numerals sequentially
in order of their citation in the body of the text.
• If a reference is cited in both the table and text,
please insert a lettered footnote in the table to refer to
the numbered reference in the text.
• Tabular data provided as additional files can be submitted
as an Excel spreadsheet.
Supportive/Supplementary Material: We do encourage to append supportive material, for example a PowerPoint file containing a talk about the study, a PowerPoint file containing additional screenshots, a Word, RTF, or PDF document showing the original instrument(s) used, a video, or the original data (SAS/SPSS files, Excel files, Access Db files etc.) provided it is inevitable or endorsed by the journal's Editor.
Any additional files will be linked into the final published article in the form supplied by the author, but will not be displayed within the paper. They will be made available in exactly the same form as originally provided only on our Web site. Please also make sure that each additional file is a single table, figure or movie (please do not upload linked worksheets or PDF files larger than one sheet). Supportive/ Supplementary material must be provided in a single zipped file not larger than 4 MB.
Authors must clearly indicate if these files are not for publication but meant for the reviewers'/editors' perusal only.
Trial registration: There should be no space between the letters and numbers of your trial registration number. All drug clinical trial studies, regardless of when they were completed, and secondary analyses of original drug clinical trial studies must be registered before submission of a manuscript based on the trial. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g., phase 1 trials), are exempt. Trial registry name, registration identification number, and the URL for the registry should be included at the end of abstract and also in the space provided on the online manuscript submission form.
Authors will submit the Trial Protocols along with their manuscript. The CONSORT (Consolidated Standards of Reporting Trials) Checklist and Flowchart is also required when submitting the results of randomized control trials (RCTs).
Ethical Approval of Studies and Informed Consent: For human or animal experimental investigations, it is a prerequisite to provide a formal review and approval, or review and waiver, by an appropriate institutional review board or ethics committee and should be documented in your paper. For investigations undertaken on human subjects, state in the Methods section the manner in which the informed consent was obtained from the study participants (i.e., oral or written), where there is an unavoidable risk of breach of privacy e.g., in a clinical photograph or in case details- the patient’s written consent or that of the next of kin, to publication must be obtained. We will ask you to send a signed consent form before publication. Consent must be obtained for all Case Reports and Drug Clinical Trial Studies.
PERMISSION FOR REPRODUCTION: Published/reproduced material should not be included unless you have obtained written permission from the copyright holder, which should be forwarded to the Editorial Office in case of acceptance of your article for publication.
For obtaining permission for reproducing any material published in an article by Bentham Science Publishers, please fill in the request FORM and send to ccp@benthamscience.org for consideration.
AUTHORS AND INSTITUTIONAL AFFILIATIONS: The
author will be required to provide their full names, the institutional
affiliations and the location, with an asterisk in front of
the name of the principal/corresponding author. The corresponding
author(s) should be designated and their complete address,
business telephone and fax numbers and e-mail address must
be stated to receive correspondence and galley proofs.
PAGE CHARGES: No page charges will be levied
to authors for the publication of their article.
LANGUAGE AND EDITING: Manuscripts submitted
containing many English typographical errors will not be published.
Authors from non-English language countries are advised to
use the services of our professional language editing department
prior to submitting their manuscript to the Journal. Please
contact Bentham Publishing Services
www.benthampublishingservices.com
for a language editing quote at e-mail: info@benthampublishingservices.com
stating the total number of words of the article to be edited.
PROOF CORRECTIONS: Authors will receive page
proofs of their accepted paper before publications. To avoid
delays in publication, proofs should be checked immediately
for typographical errors and returned within 48 hours.
Major changes are not acceptable at the proof stage. If unable
to send corrections within 48 hours due to
some reason, the author(s) must at least send an acknowledgement
on receiving the galley proofs or the article will be published
exactly as received and the publishers will not be responsible
for any error occurring in the published manuscript in this
regard.
The corresponding author will be solely responsible for ensuring
that the revised version of the manuscript incorporating all
the submitted corrections receives the approval of all the
co-authors of the manuscript.
REPRINTS: Each first-named (corresponding) author will receive electronically five free reprints. Reprints may be ordered from the Publisher prior to publication of the article. First named authors may also order a personal print and online subscription of the journal at 50% off the normal subscription rate by contacting the subscription department at e-mail: subscriptions@bentham.org.
OPEN ACCESS PLUS: Accepted articles can be published online for free open access for all to view, and be deposited by the Publishers in PubMed Central. Open access publishing provides the maximum dissemination of the article to the largest audience. Authors must pay for this service. All corresponding authors will be asked to indicate whether or not they wish to pay to have their paper made freely available on publication. If authors do not select the Open Access option, then their article will be published with standard subscription-based access at no charge.
Bentham Science offers authors the choice of open access publication of their articles at a fee of US$ 2,200 per published article which allows indefinite free-to-view online publication with Bentham Science.
For more information please contact us at e-mail: openaccess@benthamscience.org.
REVIEWING AND PROMPTNESS OF PUBLICATION: All papers submitted for publication are immediately subjected to editorial scrutiny, usually in consultation with members of the journal Editorial Advisory Board and outside independent reviewers. Every effort will be made to peer review submitted papers quickly. Papers which are delayed by authors in revision for more than 30 days will have to be re-submitted as a new submission. Papers accepted for publication are typeset and proofs are dispatched to authors for any corrections prior to final publication.
COPYRIGHT: Authors who publish in Bentham
Science print & online journals will transfer copyright
to their work to Bentham Science Publishers. Submission of
a manuscript to the respective journals implies that all authors
have read and agreed to the content of the Covering Letter
or the Terms and Conditions. It is a condition of publication
that manuscripts submitted to this journal have not been published
and will not be simultaneously submitted or published elsewhere.
Plagiarism is strictly forbidden, and by submitting the article
for publication the authors agree that the publishers have
the legal right to take appropriate action against the authors,
if plagiarism or fabricated information is discovered. By
submitting a manuscript the authors agree that the copyright
of their article is transferred to the publishers if and when
the article is accepted for publication. Once submitted to
the journal, the author will not withdraw their manuscript
at any stage prior to publication.
Plagiarism Prevention: Bentham Science Publisher uses the iThenticate software to detect instances of overlapping and similar text in submitted manuscripts. iThenticate software checks content uploaded by a journal editorial office against a database of periodicals, the Internet, and a comprehensive article database. It generates a similarity report, including the percentage overlap between the uploaded article and published material. Any instances of content overlap are treated according to a journal's peer review integrity statement and the policies recommended by the editorial Committee. You are assured that the publisher, where you are submitting your manuscript, is committed to actively combating plagiarism and publishing original research.
E-Pub Ahead of Schedule: Bentham Science
Publishers are pleased to offer electronic publication of
accepted papers prior to scheduled publication. These peer-reviewed
papers can be cited using the date of access and the unique
DOI number. Any final changes in manuscripts will be made
at the time of print publication and will be reflected in
the final electronic version of the issue. Articles ahead
of schedule may be ordered by pay-per-view at the relevant
links by each article stated via the E-Pub
Ahead of Schedule (http://www.benthamscience.com/ccp/E-Pub-Ahead-of-Schedule.htm).
Disclaimer: Articles appearing in E-Pub Ahead-of-Schedule sections have been peer-reviewed and accepted for publication in this journal and posted online before scheduled publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Bentham Science Publishers, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained of articles in the E-Pub Ahead of-Schedule.
|
